# Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers

> **NCT02063594** · PHASE1 · TERMINATED · sponsor: **Marval Pharma Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** NCTX (PEGylated Liposomal Iodixanol Injection)
- **DRUG:** Saline Placebo

## Key facts

- **NCT ID:** NCT02063594
- **Lead sponsor:** Marval Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063594, "Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02063594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*